Tg Therapeutics (TGTX) EBT Margin (2017 - 2026)
Tg Therapeutics' (TGTX) quarterly EBT Margin came in at 9.94% in Q1 2026, up 541.0% year-on-year from 1.55% in Q1 2025, and down 57.89% quarter-over-quarter from 23.6% in Q4 2025.
Tg Therapeutics (TGTX) EBT Margin (2017 - 2026) Analysis & Trends
Tg Therapeutics' EBT Margin history runs 10 years deep, the most recent figure standing at 9.94% for Q1 2026.
- On a quarterly basis, EBT Margin rose 541.0% year-over-year to 9.94% in Q1 2026; TTM through Mar 2026 was 17.51%, a 648.0% increase from a year earlier, with the FY2025 full-year figure at 17.48%, up 944.0% from the prior year.
- EBT Margin fell to 9.94% in Q1 2026 per TGTX's latest filing, from 23.6% in the prior quarter.
- Across five years, EBT Margin topped out at 68.71% in Q3 2023 and bottomed at 104777.5% in Q4 2022.
- The 5-year median for EBT Margin is 4.52% (2025), against an average of 9541.94%.
- Across the five-year window, EBT Margin sank 10064622 bps in 2022 and jumped 10474560 bps in 2023, its largest moves.
- Year by year, EBT Margin stood at 104777.5% in 2022, then soared by 100 bps to 31.9% in 2023, then jumped by 176 bps to 24.34% in 2024, then dropped by 3 bps to 23.6% in 2025, then slumped by 58 bps to 9.94% in 2026.
- Per Business Quant, the three latest TGTX EBT Margin figures stand at 9.94% (Q1 2026), 23.6% (Q4 2025), and 16.02% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tg Therapeutics | 8.88 Bn | 8.80 Bn | 171.41 Mn | 9.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.94% |
| Dec 31, 2025 | 23.60% |
| Sep 30, 2025 | 16.02% |
| Jun 30, 2025 | 21.91% |
| Mar 31, 2025 | 4.52% |
| Dec 31, 2024 | 24.34% |
| Sep 30, 2024 | 5.09% |
| Jun 30, 2024 | 8.92% |
| Mar 31, 2024 | -16.82% |
| Dec 31, 2023 | -31.90% |
| Sep 30, 2023 | 68.71% |
| Jun 30, 2023 | -296.19% |
| Mar 31, 2023 | -502.78% |
| Dec 31, 2022 | -104,777.50% |
| Sep 30, 2022 | -43,577.66% |
| Jun 30, 2022 | -9,466.33% |
| Mar 31, 2022 | -3,726.84% |
| Dec 31, 2021 | -4,131.28% |
| Sep 30, 2021 | -5,082.46% |
| Jun 30, 2021 | -5,459.35% |